NASDAQ: TYRA Tyra Biosciences, Inc. 8-K

Tyra Biosciences completes routine annual meeting, elects three directors for 2026-2029 term

Filed June 2, 2026 · Period ending May 28, 2026 · ~1 min read

2 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade TYRA commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 3, 2026 3:15 PM